Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Newtyn Management, LLC

Q2 2024 · 13F-HR

Newtyn Management, LLCholdings as filed

Filed 2024-08-14 · accession 0001493152-24-032152

$532.6M
Reported value
40
Positions
2024-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
44891N208IACIAC INC$66.8M12.5%1,425,000CommonSOLE
698884103PARPAR TECHNOLOGY CORP$45.9M8.62%975,000CommonSOLE
219798105QDELQUIDELORTHO CORP$37.0M6.95%1,115,000CommonSOLE
83444M101SOLVSOLVENTUM CORP$37.0M6.95%700,000CommonSOLE
11040G103VTOLBRISTOW GROUP INC$36.2M6.80%1,079,650CommonSOLE
03748R747AIVAPARTMENT INVT & MGMT CO$31.2M5.87%3,769,425CommonSOLE
19239V302CCOICOGENT COMMUNICATIONS HLDGS$29.6M5.56%525,000CommonSOLE
10948C107BVBRIGHTVIEW HLDGS INC$23.3M4.37%1,750,000CommonSOLE
68752M108OFIXORTHOFIX MED INC$22.1M4.15%1,667,688CommonSOLE
84790A105SPBSPECTRUM BRANDS HLDGS INC NE$21.5M4.03%249,937CommonSOLE
178587101CIOCITY OFFICE REIT INC$19.1M3.59%3,838,000CommonSOLE
G8807B106TBPHTHERAVANCE BIOPHARMA INC$18.0M3.38%2,124,703CommonSOLE
18482P103CLFDCLEARFIELD INC$16.1M3.02%417,572CommonSOLE
13765N107CNNECANNAE HLDGS INC$14.2M2.66%782,350CommonSOLE
36315X101LKFTGALAPAGOS NV$12.4M2.33%500,000CommonSOLE
83601L102SHCSOTERA HEALTH CO$11.3M2.12%950,000CommonSOLE
35471R106FSPFRANKLIN STR PPTYS CORP$10.9M2.05%7,150,000CommonSOLE
55262C100MBIMBIA INC$10.3M1.93%1,875,000CommonSOLE
05603E208BVFLBV FINL INC$9.8M1.85%826,445CommonSOLE
901384107TSVT*2SEVENTY BIO INC$9.6M1.80%2,485,000CommonSOLE
65342T106NODKNI HLDGS INC$9.3M1.74%605,499CommonSOLE
85512G106STHOSTAR HLDGS$5.7M1.06%469,718CommonSOLE
34984VAC4FORUM ENERGY TECHNOLOGIES IN$5.5M1.03%5,483,872CommonSOLE
69331C108PCGPG&E CORP$4.7M0.88%268,921CommonSOLE
315948109FBTCFIDELITY WISE ORIGIN BITCOIN$4.6M0.86%87,000CommonSOLE
294628102HP5AEQUITY COMWLTH$3.2M0.60%163,913CommonSOLE
Y95308105WVEWAVE LIFE SCIENCES LTD$2.4M0.44%475,000CommonSOLE
606710200MITKMITEK SYS INC$2.2M0.42%199,698CommonSOLE
50015M109KODKODIAK SCIENCES INC$2.2M0.41%930,000CommonSOLE
282559103ETNBGBP89BIO INC$1.9M0.36%240,000CommonSOLE
G63365103MURAMURAL ONCOLOGY PUB LTD CO$1.8M0.34%570,000CommonSOLE
00289Y206ABEOABEONA THERAPEUTICS INC$1.6M0.30%380,000CommonSOLE
68062P106OLMAOLEMA PHARMACEUTICALS INC$1.5M0.28%140,000CommonSOLE
04683R106AVIRATEA PHARMACEUTICALS INC$1.3M0.24%380,000CommonSOLE
097702104BOLT1EURBOLT BIOTHERAPEUTICS INC$1.0M0.19%1,363,234CommonSOLE
384747101GRALGRAIL INC$526,7150.10%34,269CommonSOLE
09203E105BDTXBLACK DIAMOND THERAPEUTICS I$442,7000.08%95,000CommonSOLE
34984V209FETFORUM ENERGY TECHNOLOGIES IN$252,9000.05%15,000CommonSOLE
01626L105ALIGOS THERAPEUTICS INC$251,7500.05%719,287CommonSOLE
52178J113LFLYWLEAFLY HOLDINGS INC$9,8370.00%634,640CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.